This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

John AI Grossman MD (Photo: Business Wire)

Miami Children’s Hospital, recognized by U.S. News & World Report for excellence in 10 pediatric subspecialties in 2011 and 2012, and AxoGen, Inc. (OTCBB: AXGN) have announced the hospital’s first nerve repair surgery with Avance® Nerve Graft. The processed nerve allograft technology was implanted during a surgery recently to repair a brachial plexus injury suffered by a 6 month-old baby girl.

John AI Grossman MD (Photo: Business Wire)

John AI Grossman MD (Photo: Business Wire)

The surgery was performed by Dr. John A. I. Grossman, MD, FACS, Director of The Brachial Plexus Program at Miami Children’s Hospital, Clinical Associate Professor of Orthopedic Surgery at New York University’s School of Medicine, author of numerous studies on pediatric brachial plexus repair and an associate editor of the Journal of Brachial Plexus and Peripheral Nerve Injury. “The Avance® Nerve Graft is changing how we approach the surgical reconstruction of injured brachial plexus nerves and is a very valuable new tool,” offered Dr. Grossman.

The brachial plexus controls the movement of muscles and sensation in the shoulder, arm and hand. Brachial plexus injuries may occur if an infant’s neck is excessively stretched during birth or by traumatic injury. If left untreated, brachial plexus birth injuries can have lifelong consequences including paralysis or limited movement, numbness and weakness in the shoulder, arm, hand and fingers.

Dr. Grossman, who works at both Miami Children’s Hospital and NYU Hospital for Joint Diseases, runs one of the busiest programs in the country for treating these types of injuries. Depending on the severity of the injury, treatment often involves surgical repair and replacement of injured or torn nerves. Historically, healthy nerve was taken from elsewhere in the patient’s body and used to repair the damaged nerve in a procedure known as an autograft. Limitations in the amount of healthy nerve available for grafting created a market need for a nerve substitute. Dr. Grossman added, “Avance® Nerve Graft is the closest you can get to the patient’s own nerve in terms of structure, size and compatibility with the body’s healing processes. The technology also assures that we will have enough graft material to complete a successful surgical repair.”

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,080.14 +21.45 0.12%
S&P 500 2,117.69 +4.76 0.23%
NASDAQ 5,092.0850 +36.0220 0.71%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs